• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素特异性肽酶 49 通过抑制 PI3K/AKT 信号通路抑制非小细胞肺癌细胞生长。

Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Department of Emergency Surgery, The Affiliated Wujin People's Hospital of Jiangsu University, Changzhou, Jiangsu, China.

出版信息

Kaohsiung J Med Sci. 2019 Jul;35(7):401-407. doi: 10.1002/kjm2.12073. Epub 2019 Apr 18.

DOI:10.1002/kjm2.12073
PMID:31001918
Abstract

Ubiquitin specific peptidase 49 (USP49) has been reported as a tumor suppressor in several tumors, but its function and molecular mechanism in non-small cell lung cancer (NSCLC) are still unknown. In this study, USP49 was found downregulated in NSCLC primary tissues and cell lines, and high USP49 predicted a positive index for the overall survival of NSCLC patients. Overexpression of USP49 downregulated the expression levels of Cyclin D1, and upregulated p53 expression. Further flow cytometry analysis showed that overexpressed USP49 induced cell cycle arrest at G0/G1 phase. As a result, overexpression of USP49 significantly inhibited cell growth of NSCLC cells. In mechanism, overexpression of USP49 inhibited PI3K/AKT signaling, but knockdown of USP49 enhanced this signaling. Further studies indicated that USP49 deubiquitinated PTEN and stabilized PTEN protein, which suggested that USP49 inhibited PI3K/AKT signaling by stabilizing PTEN in NSCLC cells. In conclusion, we demonstrated that USP49 was functional in NSCLC cells, and inhibited NSCLC cell growth by suppressing PI3K/AKT signaling, suggesting that USP49 could be as a novel target for NSCLC therapy.

摘要

泛素特异性肽酶 49(USP49)已在多种肿瘤中被报道为肿瘤抑制因子,但它在非小细胞肺癌(NSCLC)中的功能和分子机制尚不清楚。在本研究中,发现 USP49 在 NSCLC 原发组织和细胞系中下调,高 USP49 预测 NSCLC 患者总生存率呈阳性指数。USP49 的过表达下调了 Cyclin D1 的表达水平,并上调了 p53 的表达。进一步的流式细胞术分析表明,过表达 USP49 诱导细胞周期停滞在 G0/G1 期。结果,过表达 USP49 显著抑制 NSCLC 细胞的生长。在机制上,过表达 USP49 抑制了 PI3K/AKT 信号通路,但 USP49 的敲低增强了这种信号通路。进一步的研究表明,USP49 去泛素化了 PTEN 并稳定了 PTEN 蛋白,这表明 USP49 通过在 NSCLC 细胞中稳定 PTEN 来抑制 PI3K/AKT 信号通路。总之,我们证明了 USP49 在 NSCLC 细胞中具有功能,通过抑制 PI3K/AKT 信号通路抑制 NSCLC 细胞生长,提示 USP49 可能成为 NSCLC 治疗的新靶点。

相似文献

1
Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.泛素特异性肽酶 49 通过抑制 PI3K/AKT 信号通路抑制非小细胞肺癌细胞生长。
Kaohsiung J Med Sci. 2019 Jul;35(7):401-407. doi: 10.1002/kjm2.12073. Epub 2019 Apr 18.
2
Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.三结构域蛋白 26 的过表达通过抑制 PI3K/AKT 信号通路抑制非小细胞肺癌细胞的生长。
Kaohsiung J Med Sci. 2020 Jun;36(6):417-422. doi: 10.1002/kjm2.12194. Epub 2020 Feb 12.
3
Ubiquitin-specific protease 44 inhibits cell growth by suppressing AKT signaling in non-small cell lung cancer.泛素特异性蛋白酶 44 通过抑制非小细胞肺癌中的 AKT 信号通路抑制细胞生长。
Kaohsiung J Med Sci. 2019 Sep;35(9):535-541. doi: 10.1002/kjm2.12096. Epub 2019 Jun 14.
4
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
5
MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.MicroRNA-4286 通过调控 PTEN 对 PI3K/Akt 通路促进非小细胞肺癌细胞的增殖、迁移和侵袭。
Cancer Med. 2019 Jul;8(7):3520-3531. doi: 10.1002/cam4.2220. Epub 2019 May 10.
6
MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.微小RNA-122-5p通过下调p53并激活PI3K-AKT信号通路促进非小细胞肺癌的发展。
J BUON. 2019 Jan-Feb;24(1):273-279.
7
Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.长非编码 RNA FER1L4 通过 PTEN/AKT/p53 信号通路抑制肺癌细胞增殖并促进细胞凋亡。
Oncol Rep. 2021 Jan;45(1):359-367. doi: 10.3892/or.2020.7861. Epub 2020 Nov 19.
8
Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/ Pathway in Lung Adenocarcinoma A549 Cells.通过下调肺腺癌A549细胞中的PI3K/AKT/信号通路抑制细胞增殖、促进细胞凋亡并诱导细胞周期停滞。
Biomed Res Int. 2016;2016:2476842. doi: 10.1155/2016/2476842. Epub 2016 Oct 16.
9
Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.miR-374a 通过调节 c-Jun 分别靶向 CCND1 诱导的 PI3K/AKT 信号和 PTEN 抑制的 Wnt/β-catenin 信号在非小细胞肺癌中的双重作用。
Cell Death Dis. 2018 Jan 23;9(2):78. doi: 10.1038/s41419-017-0103-7.
10
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.

引用本文的文献

1
Genetically predicted effects of 10 sleep phenotypes on revision of knee arthroplasty: a mendelian randomization study.基于遗传预测的 10 种睡眠表型对膝关节置换术翻修的影响:一项孟德尔随机化研究。
J Orthop Surg Res. 2024 Sep 12;19(1):563. doi: 10.1186/s13018-024-05031-0.
2
The equilibrium of tumor suppression: DUBs as active regulators of PTEN.肿瘤抑制的平衡:DUBs 作为 PTEN 的活性调节剂。
Exp Mol Med. 2022 Nov;54(11):1814-1821. doi: 10.1038/s12276-022-00887-w. Epub 2022 Nov 16.
3
Knockdown of USP8 inhibits prostate cancer cell growth, proliferation, and metastasis and promotes docetaxel's activity by suppressing the NF-kB signaling pathway.

本文引用的文献

1
miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.miR-494-3p 通过调控 PTEN/PI3K/AKT 通路促进子宫内膜癌的进展。
Mol Med Rep. 2019 Jan;19(1):581-588. doi: 10.3892/mmr.2018.9649. Epub 2018 Nov 13.
2
GAP43, a novel metastasis promoter in non-small cell lung cancer.GAP43,一种非小细胞肺癌中的新型转移促进因子。
J Transl Med. 2018 Nov 12;16(1):310. doi: 10.1186/s12967-018-1682-5.
3
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
USP8基因敲低可抑制前列腺癌细胞的生长、增殖和转移,并通过抑制NF-κB信号通路增强多西他赛的活性。
Front Oncol. 2022 Oct 20;12:923270. doi: 10.3389/fonc.2022.923270. eCollection 2022.
4
Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma.Rho家族GTP酶1(RND1)是一种新型的p53调节因子,可增强胶质母细胞瘤中的铁死亡。
Cell Biosci. 2022 May 3;12(1):53. doi: 10.1186/s13578-022-00791-w.
5
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation.Fbxo45 通过靶向 USP49 促进胰腺癌的进展。
Cell Death Dis. 2022 Mar 12;13(3):231. doi: 10.1038/s41419-022-04675-2.
6
Oncogenic Activity of Glucocorticoid Receptor β Is Controlled by Ubiquitination-Dependent Interaction with USP49 in Glioblastoma Cells.成胶质细胞瘤细胞中糖皮质激素受体 β 的致癌活性受与 USP49 泛素化依赖性相互作用的控制。
Mol Cancer Res. 2022 Jan;20(1):92-101. doi: 10.1158/1541-7786.MCR-20-1068. Epub 2021 Oct 5.
7
Advances in deubiquitinating enzymes in lung adenocarcinoma.肺腺癌中去泛素化酶的研究进展
J Cancer. 2021 Jul 25;12(18):5573-5582. doi: 10.7150/jca.56532. eCollection 2021.
8
miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer.微小RNA-5000-3p通过靶向泛素特异性肽酶49赋予结直肠癌对奥沙利铂的耐药性。
Cell Death Discov. 2021 Jun 1;7(1):129. doi: 10.1038/s41420-021-00494-0.
9
Long non-coding RNA receptor activator of nuclear factor-κ B ligand promotes cisplatin resistance in non-small cell lung cancer cells.长链非编码RNA核因子κB配体受体激活剂促进非小细胞肺癌细胞的顺铂耐药性。
Exp Ther Med. 2021 May;21(5):518. doi: 10.3892/etm.2021.9949. Epub 2021 Mar 22.
10
PTPLAD2 and USP49 Involved in the Pathogenesis of Smoke-Induced COPD by Integrative Bioinformatics Analysis.PTPLAD2 和 USP49 通过综合生物信息学分析参与吸烟诱导 COPD 的发病机制。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 15;15:2515-2526. doi: 10.2147/COPD.S250576. eCollection 2020.
培美曲塞维持治疗 III 期临床试验在非鳞非小细胞肺癌中的应用:重点关注 2 年总生存率和治疗连续性。
Clin Lung Cancer. 2018 Nov;19(6):e823-e830. doi: 10.1016/j.cllc.2018.05.013. Epub 2018 May 26.
4
Cross-Dysregulation of -GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases.人类慢性疾病中O-连接N-乙酰葡糖胺化与PI3K/AKT/mTOR轴的交叉失调
Front Endocrinol (Lausanne). 2018 Oct 9;9:602. doi: 10.3389/fendo.2018.00602. eCollection 2018.
5
mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53.mTOR 激酶通过磷酸化 p53 导致 PTEN 缺失诱导的细胞衰老。
Oncogene. 2019 Mar;38(10):1639-1650. doi: 10.1038/s41388-018-0521-8. Epub 2018 Oct 18.
6
Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling.RNF6基因敲低通过抑制STAT3信号传导抑制胃癌细胞生长。
Onco Targets Ther. 2018 Oct 5;11:6579-6587. doi: 10.2147/OTT.S174846. eCollection 2018.
7
PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes.非小细胞肺癌包括各种腺癌亚型中的程序性死亡受体配体1(PD-L1)表达
Ann Thorac Cardiovasc Surg. 2019 Feb 20;25(1):1-9. doi: 10.5761/atcs.oa.18-00163. Epub 2018 Oct 3.
8
USP49 inhibits ischemia-reperfusion-induced cell viability suppression and apoptosis in human AC16 cardiomyocytes through DUSP1-JNK1/2 signaling.USP49 通过 DUSP1-JNK1/2 信号通路抑制缺血再灌注诱导的人 AC16 心肌细胞活力抑制和凋亡。
J Cell Physiol. 2019 May;234(5):6529-6538. doi: 10.1002/jcp.27390. Epub 2018 Sep 24.
9
Regulation of PTEN expression by noncoding RNAs.非编码 RNA 对 PTEN 表达的调控。
J Exp Clin Cancer Res. 2018 Sep 10;37(1):223. doi: 10.1186/s13046-018-0898-9.
10
RING finger protein 38 induces gastric cancer cell growth by decreasing the stability of the protein tyrosine phosphatase SHP-1.RING 指蛋白 38 通过降低蛋白质酪氨酸磷酸酶 SHP-1 的稳定性诱导胃癌细胞生长。
FEBS Lett. 2018 Sep;592(18):3092-3100. doi: 10.1002/1873-3468.13225. Epub 2018 Aug 29.